Medications for Atrial Fibrillation
95 results
Apixaban (apixaban)
(Apixaban)Macleods Pharmaceuticals Limited
Usage: Apixaban is indicated for reducing stroke and systemic embolism risk in nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis following hip or knee surgery, and treatment of deep vein thrombosis and pulmonary embolism. It also reduces the risk of recurrent DVT and pulmonary embolism after initial therapy.
Betapace (sotalol hcl)
(sotalol HCl)Skyepharma Production SAS
Usage: Betapace/Betapace AF is indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia, and for delaying recurrence of highly symptomatic atrial fibrillation/atrial flutter in patients currently in sinus rhythm. It is not intended for patients with easily reversible paroxysmal atrial fibrillation.
Corvert (ibutilide fumarate)
(ibutilide fumarate)Pharmacia & Upjohn Company LLC
Usage: CORVERT Injection is indicated for the rapid conversion of recent-onset atrial fibrillation or atrial flutter to sinus rhythm. It is less effective in patients with arrhythmias lasting longer than 90 days, as its effectiveness in such cases has not been established.
Dabigatran etexilate (dabigatran etexilate)
(dabigatran etexilate)Apotex Corp.
Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing their recurrence, and prophylaxis following hip replacement surgery in adult patients.
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran Etexilate)Mylan Pharmaceuticals Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran etexilate)Dr. Reddy's Laboratories Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing stroke risk in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, providing prophylaxis following hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to under 18 years.
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran Etexilate)Alembic Pharmaceuticals Limited
Usage: Dabigatran etexilate is indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing recurrence of these conditions, and prophylaxis following hip replacement surgery in adults.
Digoxin (digoxin)
(Digoxin)REMEDYREPACK INC.
Usage: Digoxin tablets are indicated for treating mild to moderate heart failure in adults and pediatric patients, enhancing myocardial contractility. They also control ventricular response rate in adults with chronic atrial fibrillation, improving exercise capacity and reducing hospitalizations, but do not affect mortality.
Digoxin (digoxin)
(Digoxin)Golden State Medical Supply, Inc.
Usage: Digoxin Tablets are indicated for treating mild to moderate heart failure in adults and pediatric patients, improving heart function and symptoms. They are also used to control the ventricular response rate in adults with chronic atrial fibrillation, enhancing exercise capacity without affecting mortality rates.
Digoxin (digoxin)
(Digoxin)Jerome Stevens Pharmaceuticals, Inc.
Usage: Digoxin is indicated for treating mild to moderate heart failure, improving left ventricular ejection fraction and symptoms, without affecting mortality. It is also used to control ventricular response rate in patients with chronic atrial fibrillation. Combination therapy with diuretics and ACE inhibitors is recommended when possible.
- ...